Subscribe
shutterstock_1743001619_glen_berlin
Glen Berlin / Shutterstock.com
22 June 2023EuropeMarisa Woutersen

UK appoints first female Lord Chief Justice in 755 years

Dame Sue Carr takes over from Lord Burnett of Maldon, assuming responsibilities in October.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.
Biotechnology
Genentech refused appeal in Herceptin case
27 May 2014   Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.
Big Pharma
LSIPR 50 2017: Mr Justice Richard Arnold
10 November 2017   Mr Justice Richard Arnold was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.
Biotechnology
Genentech refused appeal in Herceptin case
27 May 2014   Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.
Big Pharma
LSIPR 50 2017: Mr Justice Richard Arnold
10 November 2017   Mr Justice Richard Arnold was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

More on this story

Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.
Biotechnology
Genentech refused appeal in Herceptin case
27 May 2014   Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.
Big Pharma
LSIPR 50 2017: Mr Justice Richard Arnold
10 November 2017   Mr Justice Richard Arnold was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility